Daratumumab: new indications revolving around "off-targets"

Haematologica. 2021 Dec 1;106(12):3032-3033. doi: 10.3324/haematol.2021.279487.
No abstract available

Publication types

  • Comment

MeSH terms

  • ADP-ribosyl Cyclase 1
  • Antibodies, Monoclonal* / therapeutic use
  • Humans

Substances

  • Antibodies, Monoclonal
  • daratumumab
  • ADP-ribosyl Cyclase 1